Provider of organ perfusion services intended to serve the people of Canada. The company's service helps to restore the function of donor organs, enabling people to get a new life.

A modern, upscale Mexican restaurant coming soon to Washington, D.C.

Telefónica is today one of the largest telecommunications companies in the world in terms of market capitalisation and number of customers. We have the best infrastructure, as well as an innovative range of digital and data services; therefore, we are favorably positioned to meet the needs of our customers and capture growth in new businesses. We are sensitive to the new challenges demanded by society today and, therefore, we provide the means to facilitate communication between people, providing them with the most secure and cutting-edge technology. Our vision is focused on technology making people's lives easier and our aim is to promote progress in that direction, so that technology can make a positive impact on the world both socially and environmentally, and, ultimately, so as to provide value and trust in an ever-changing and accelerating world. Digital life is life itself, and technology is an essential part of being human. We want to create, protect and boost connections in life so people can choose a world of unlimited possibilities. We want to be a company in which our clients, employees, suppliers, shareholders, and society in general can trust. In order to achieve this, we communicate our strategy, business model and most relevant data to our stakeholders in a clear and transparent manner, so as to show the company's ability to create value.

NARA is an multi-strategy investment firm with the purpose of making a positive difference in the society and environment. The company is a regulated AIFM under the authorization and supervision of the Spanish Securities and Exchange Commission (CNMV). We currently manage 3 strategies: NARA VENTURES is a fund of top tier VC funds that invests globally. We co-manage the fund with PlugAndPlay, a pioneer investor in Silicon Valley with more than 35 unicorns. NARA HEALTH backs purpose driven entrepreneurs who are reimagining healthcare. Just like IT has changed the world BIO is on the precipice of changing every aspects of our lives. NARA HEALTH has been the winner of the 14th Fond-ICO call in the Tech Transfer category. NARA SUSTAINABILITY accelerates the transformation of the energy sector towards a Net-Zero world. The fund invests in the origination and development of new projects in photovoltaic solar, wind, hydrogen and storage.

ODN Europe is a membership association for organisation development and design, throughout Europe and the UK. ODNE is a chapter of the Organisation Development Network (ODN) and both organisations exist to advance the field of OD, working with their members and stakeholders to build understanding, scholarship and practice in all aspects of people-focussed work in organisations. ODNE offers opportunities for development, networking, scholarship and connection for our diverse membership, through individual and corporate memberships, a diverse programme of online and face to face events, and a network of regional groups.

mybacs is a research-driven DTC company specialized in the human microbiome. Our goal is to revolutionize the market around intestinal healthcare and thus make a decisive contribution to the daily well-being of our customers. Our team of pharmaceutical scientists and physicians is focused on the development of innovative and highly-dosed synbiotic supplements. These are aligned by our singular formulations from specifically selected probiotic cultures, prebiotics as well as minerals and vitamins tailored to the individual needs of our customers.

It takes more than capital to build real-world, cutting-edge technologies and companies that last. That’s why we commit the full power of our sector-focused investment teams and global network of customers, talent, top-tier follow-on investors, industry leaders, and experienced entrepreneurs to help you scale smarter and faster. With offices in London, Berlin, Paris, Vienna, and Abu Dhabi, we are on the ground across EMEA, helping our portfolio companies own their local markets and expand globally. From pre-seed to exit, we partner with bold founders to build category-defining, lasting companies like Bitpanda (Austria), Wayflyer (Ireland), Moove (Nigeria), Gigs (US), GoStudent (Austria), Tide (UK), ARX Robotics (Germany), Seqera Labs (Spain), and Cylib (Germany) – together. Speedinvest: The Power of More.

Savana breaks down the barriers between assisted and self-service channels to enable frictionless interactions between your banks and its customers

At Psyomics, we’re helping people get the mental health support they need, sooner. Led by CEO Dr Melinda Rees, Psyomics aims to revolutionise the way we assess, diagnose, triage, and treat mental health. Cambridge University Biotech spinout turned Healthtech, Psyomics was founded by Professor Sabine Bahn, Laboratory Director at the Cambridge Centre for Neuropsychiatric Research. Following more than six years of research and development, the Psyomics Platform significantly reduces clinical triage and assessment time through dynamic patient-reported information capture. Launching in late 2022 for the assessment and triage of 15+ mental health conditions, used by more than 8,500 patients to date.

S3 Connected Health helps you leverage digital technologies to make a real difference to healthcare outcomes. S3 Connected Health breadth of experience across therapy areas, technologies and territories means they can truly be your global partner delivering scalable solutions that make a difference.

Businesses and individuals considering investment into Cyprus have a partner on the ground at all stages of the investment cycle. Invest Cyprus is a non-profit national body and the government’s dedicated partner responsible for attracting and facilitating Foreign Direct Investment in key economic sectors. Being the lead agent in establishing Cyprus as a world-class investment destination, Invest Cyprus proactively promotes the enhancement of the country’s competitive environment, advocating reform and maximising FDI, for the economic and social benefit of Cyprus. In close collaboration with all government authorities, public institutions and the private sector, Invest Cyprus is the investor’s first point of contact. Invest Cyprus is a member of the World Association of Investment Promotion Agencies (WAIPA) and the Mediterranean Investment Network, ANIMA

The company primarily operates in the IT Consulting and Outsourcing industry. Dieter von Holtzbrinck Ventures was founded in 2014 and is headquartered in Cologne, Germany.

Sopharma PLC is one of the leading pharmaceuticals company in Bulgaria popular with manufacturing of high-quality medicines, modern businessethic and social responsibility. The highly technological process for development and production of our products is licensed according to the GPP - Good Production Practices.

The company primarily operates in the IT Consulting and Outsourcing industry. Dieter von Holtzbrinck Ventures was founded in 2014 and is headquartered in Cologne, Germany.

Our diverse and highly experienced team provides a national reach in providing funding in support of SMEs and mid-Corporates’ growth ambitions. As a key provider of growth capital, often in tandem with a business’ primary funder(s) but also in isolation, we take that proven relationship approach, in understanding the challenges that accompany any growth plan and how and where Mercia Debt can play a supportive role. We offer loan capital from £100k up to £10m across the wide range of debt funds that we manage, on behalf of and in partnership with numerous institutional investors. Those funds can support the working capital need that accompanies growth plans, development capital for projects requiring asset investment or funding that supports a strategic change in ownership.

Investing in start-ups that will fundamentally change the way cancer care is designed and delivered at scale. @OncoVentures on Twitter

Asabys Partners is a venture capital firm from Barcelona investing across the board in human healthcare. We are active in the health-tech and biopharma industries and aim to invest in Spain and abroad in highly innovative and transformative technologies. We are motivated by the idea of pushing the boundaries of science and medicine. We do this through the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry. We have an entrepreneurial spirit and seek to be involved in the building and management of our companies. Not just investors, we consider ourselves as partners and collaborators to our portfolio companies.

We develop digital products that go beyond current trends and needs. We provide solutions within a very short time span to improve both, patients' health and the industry. For wide-ranging, in-depth healthcare knowledge, we rely on our mother company Boehringer Ingelheim and the expertise of 50,000 Boehringer Ingelheim colleagues.

We are the leader of the SAP services market in Poland. As part of the All for One Group, we co-create a group of companies with a leading position in Central Europe’s SAP market. We provide IT security and software development services. We provide solutions for the digitalization of processes and develop tailor-made software. There are over 500 of us: SAP consultants, programmers and IT experts, project managers and business specialists. We previously operated as SNP Poland and BCC.

Welcome to Kiffik Animal Health. We are pioneering the next generation of medical wearables and real-time diagnostics for humans and animals through the power of interstitial fluid (ISF). Bio-rich ISF, the body's information 'super highway', decodes health and wellness information from thousands of protein and biomarker families, leading to earlier awareness and diagnosis. https://lnkd.in/dic2rZdB

What makes Coloplast Advanced Wound Dressings special is our willingness to listen to the people who use our products, and act on what we learn. By listening, we gain a better understanding of the challenges healthcare professionals face when caring for wounds, and of new ways to improve quality of life for patients living with wounds. This knowledge inspires the intelligent design of our products. By combining advanced healing technology with user-friendliness we promote optimal conditions for keeping skin healthy and helping wounds heal. Our award-winning design is supported by clinical evidence. We recognise that caring for wounds and skin can be a complex and uncertain process. So we dedicate ourselves to sharing deeper knowledge and guidance through our internationally endorsed education programmes with the goal of raising the global standard of care. The guidance and tools we provide are practical and intuitive, enabling healthcare professionals to efficiently and confidently manage wounds and skin complications. Through closer collaboration with healthcare professionals we build long-lasting and rewarding partnerships. As a present and competent partner, we tailor solutions to be sensitive to individual needs, and optimise treatment programmes with the aim of increasing both the effectiveness of care and the certainty of successful outcomes. Together, we are united by a shared purpose and passion to achieve Fewer days with wounds.

Founded in 2006, CHI Software has been at the forefront of transforming business challenges into technological solutions. Leveraging the power of AI, generative AI, cloud computing, and advanced data engineering, we apply these cutting-edge technologies to real-world business cases across mobile and web platforms. In 2019, we launched our AI R&D Centre, further reinforcing our commitment to innovation. Together, Beyond Expectations, we partner with our clients to create solutions that not only meet but exceed their goals, driving lasting success.

The Mount Sinai Health System is an integrated health care system providing exceptional medical care to their local and global communities. Encompassing the Icahn School of Medicine at Mount Sinai and seven hospital campuses in the New York metropolitan area, as well as a large, regional ambulatory footprint, Mount Sinai is internationally acclaimed for its excellence in research, patient care, and education across a range of specialties. The Mount Sinai Health System was created from the combination of the Mount Sinai Medical Center and Continuum Health Partners, which both agreed unanimously to combine the two entities in July 2013. The Health System is designed to increase efficiencies and economies of scale; improve quality and outcomes; and expand access to advanced primary, specialty, and ambulatory care services throughout a wide clinical network. The Health System includes more than 7,000 primary and specialty care physicians and 12 minority-owned free-standing ambulatory surgery centers. Mount Sinai also features a robust and continually expanding network of multispecialty services, including more than 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island. It has more than 40 clinical and academic relationships with other local health care organizations. Mount Sinai physicians can be found in more than 300 community locations throughout the New York metropolitan area. With an extraordinary array of resources for the provision of compassionate, state-of-the-art care, the Mount Sinai Health System is poised to identify and respond to the health-related needs of the diverse populations they serve.

DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, and proprietary deep learning-based cell engineering tools. Our goal is to supplement in vitro testing with in silico simulations and rapidly discover molecular triggers to efficiently engineer cell behavior. We are working closely with biotech and pharmaceutical companies to accelerate their target identification processes. We are also collaborating actively with the academic community by publishing papers and providing open access to our platform’s features and data.

Salud Family Health is a Federally Qualified Health (FQHC) operating 13 clinic locations, 11 school sites and a mobile unit. We provide medical, dental, pharmacy, and behavioral health care services to keep our communities healthy. We focus on low-income, medically underserved populations as well as the migrant and seasonal farmworker population. Since 1970, Salud remains committed to providing care to all community members regardless of finances, insurance coverage, or ability to pay. Follow us on Facebook, Instagram and Twitter/X: https://www.facebook.com/SaludFamilyHealth https://www.instagram.com/saludfamilyhealth https://twitter.com/saludclinic